RRejuveron Life Sciences AG

Rejuveron

This biotechnology firm develops medicines and regenerative therapies targeting age-related diseases to improve healthspan for the aging population.

Rejuveron Life Sciences

This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.

Life Biosciences

This biotechnology company develops cellular rejuvenation therapies using epigenetic restoration to treat age-related diseases, such as optic neuropathies, for patients with chronic conditions.

Endogena Therapeutics

This biotech company develops small-molecule regenerative medicines to repair tissues and organs for patients with degenerative eye diseases and genetic disorders.

clock.bio

This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.

RejuverSen

This biotechnology firm develops senolytic therapies to eliminate senescent cells for treating cancer, fibrosis and age-related diseases in humans.

Ikarovec

This company develops bicistronic gene therapies to treat chronic ophthalmic diseases, such as age-related macular degeneration, for patients suffering from vision loss.

Vedere Bio

This biotechnology company develops ocular gene therapies to restore functional vision for patients with inherited retinal degenerations and geographic atrophy.